Takeda
|
4,065.00 |
|
132.00 |
3.36% |
-0.76% |
2025-04-14 |
AbbVie
|
174.88 |
|
1.01 |
0.58% |
7.92% |
2025-04-11 |
Agios Pharmaceuticals
|
26.70 |
|
1.39 |
5.49% |
-9.52% |
2025-04-11 |
ALKERMES
|
27.00 |
|
0.41 |
1.54% |
10.57% |
2025-04-11 |
Amgen
|
285.87 |
|
4.62 |
1.64% |
7.05% |
2025-04-11 |
Biogen
|
115.15 |
|
1.69 |
1.49% |
-43.44% |
2025-04-11 |
BioMarin Pharmaceutical
|
56.82 |
|
0.50 |
0.89% |
-38.39% |
2025-04-11 |
Bristol-Myers Squibb
|
50.67 |
|
0.22 |
0.44% |
4.89% |
2025-04-11 |
Exelixis
|
35.31 |
|
0.85 |
2.47% |
54.80% |
2025-04-11 |
Genmab
|
1,272.50 |
|
47.50 |
3.88% |
-38.17% |
2025-04-14 |
Gilead Sciences
|
103.58 |
|
2.30 |
2.27% |
52.19% |
2025-04-11 |
GlaxoSmithKline
|
1,313.75 |
|
19.75 |
1.53% |
-20.06% |
2025-04-14 |
Glaxosmithkline
|
34.64 |
|
1.04 |
3.10% |
-14.81% |
2025-04-11 |
Incyte
|
56.87 |
|
1.70 |
3.08% |
5.61% |
2025-04-11 |
Ionis Pharmaceuticals
|
27.90 |
|
1.19 |
4.46% |
-33.16% |
2025-04-11 |
J&J
|
151.59 |
|
3.09 |
2.08% |
2.79% |
2025-04-11 |
Eli Lilly
|
731.83 |
|
11.89 |
1.65% |
-2.50% |
2025-04-11 |
Merck
|
79.14 |
|
1.68 |
2.17% |
-37.01% |
2025-04-11 |
Moderna
|
26.20 |
|
1.72 |
7.03% |
-75.53% |
2025-04-11 |
Neurocrine Biosciences
|
90.87 |
|
0.15 |
0.17% |
-32.52% |
2025-04-11 |
Novartis
|
88.07 |
|
1.98 |
2.30% |
1.82% |
2025-04-14 |
Novartis
|
107.54 |
|
3.71 |
3.57% |
14.89% |
2025-04-11 |
Pfizer
|
21.89 |
|
0.33 |
1.53% |
-15.42% |
2025-04-11 |
PTC Therapeutics
|
42.98 |
|
2.69 |
6.68% |
62.68% |
2025-04-11 |
Ultragenyx Pharmaceutical
|
34.14 |
|
0.98 |
2.96% |
-27.36% |
2025-04-11 |
Regeneron Pharmaceuticals
|
553.76 |
|
7.44 |
1.36% |
-38.75% |
2025-04-11 |
Roche Holding
|
250.20 |
|
6.40 |
2.63% |
11.15% |
2025-04-14 |
Sanofi
|
91.61 |
|
1.99 |
2.22% |
4.76% |
2025-04-14 |
Sarepta Therapeutics
|
51.03 |
|
0.72 |
1.43% |
-58.47% |
2025-04-11 |
Teva Pharmaceutical Industries
|
5,068.00 |
|
59.00 |
1.18% |
1.77% |
2025-04-14 |
Vertex Pharmaceuticals
|
484.02 |
|
8.30 |
1.74% |
22.10% |
2025-04-11 |